Select Page

JOHOR BAHRU, 13 March 2018 – Institute Bioproduct Development (IBD) Universiti Teknologi Malaysia (UTM) has conducted a three day course on cGMP Facility (Pharmaceutical and Biopharmaceuticals) for the German world known high-tech design and Contractor Company M+ W Group has successfully concluded today.

The course was attended by eight M+W senior and junior project managers, engineers, and Quality Assurance and Quality Control Managers. The program serves as an initiation towards further long-term cooperation with M+W Group with IBD’s role as the training provider for its employees and clients.

IBD consistently conducts courses of relevance to the industry, in which our program approach combines theoretical and practical know-how to the participants by leveraging on our technology experts and technical facilities. For this particular course, the program was headed and taught by Prof. Dr. rer. Nat. Hesham A. El Enshasy, who has more than 20 years experience as a consultant to biopharmaceutical industries. Additionally, IBD’s Bioprocessing Technology Platform provides real case studies to participants to engage in the process of establishing and maintaining a cGMP facility.

M+W Group GmbH, is a German company established in 1912 and has a presence in more than 30 countries with an estimation of 6,000 employees. The company is one of the global leaders in the design, engineering and construction of high tech facilities and major complex projects in different sectors including Biopharmaceuticals, Pharmaceuticals, Electronics, Chemicals, Energy, and Information Technology worldwide. The next course is scheduled to be conducted on the 13th and 14th August 2018, at IBD UTM Johor Bahru.